Clinical trial · Observational
Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19
Assessing the Provider Implementation and Experience of TeleHealth During COVID-19 and Impact on Acute Encounters
NCT04357574CI-TRIAL-00102621CORONA-SHIELDenrolling by invitationClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The primary objective of this research study is to assess Radiation Oncology healthcare providers (i.e. faculty, residents and advanced practice providers (APPs) implementation and perception of telehealth for on treatment patients in lieu of in person on treatment visits during standard of care radiotherapy during COVID-19.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| COVID-19 | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Telehealth | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Radiation Oncology Providers
- description
- Faculty physicians, residents and advanced practice providers in the Radiation Oncology Department in Duke University Health System (DUHS)
- interventionNames
- Other: Telehealth
Primary outcomes (1)
- measure
- Radiation Oncology providers perception of of telehealth for on treatment patients in lieu of in person on treatment visits during COVID-19
- timeFrame
- 12 months
- description
- survey assessment scored as strongly agree (positive perception) through strongly disagree (negative perception)
Secondary outcomes (3)
- measure
- Number of missed telehealth clinical evaluation visits during COVID-19
- timeFrame
- 12 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: • started outpatient radiation therapy with or without concurrent systemic therapy at Duke Cancer Center during the COVID-19 outbreak Exclusion Criteria: * undergoing total body radiation therapy for hematopoetic stem cell transplantation * undergoing therapy as inpatient * completed radiation therapy prior to algorithm execution
References
Publications (0)
Data not yet available
No reference posted for this study.